Clinuvel Pharmaceuticals Limited Financials

Market Capitalization A$851.7 Million as of July 1, 2024

Valuations Metrics as of May. 5, 2024

Trailing PE	26.07
Forward PE	20.08
Price to Sales TTM	A$9.11
Price to Book MRQ	A$4.12
Enterprise to Revenue	6.89
Enterprise to EBITDA	12.69

Financial Reports as of Jun. 30, 2023

Financials

Fiscal Year Ends	2023-06-30
Most Recent Quarter	2023-06-30
Profit Margin	36.88%
Operating Margin	42.37%
Return on Assets TTM	14.71%
Return on Equity TTM	18.98%

Income Statement

Revenue TTM	A$81,756,784
Revenue per Share TTM	A$1.65
Quarterly Revenue Growth	11.70%
Gross Profit TTM	A$69,531,797
EBITDA	A$49,560,844
Net Income to Common TTM	A$30,152,934
Diluted EPS TTM	A$0.57
Quarterly Earnings Growth YoY	-4.00%

Balance Sheet

Total Cash MRQ	A$174,449,200
Total Cash per Share MRQ	A$3.52
Total Debt MRQ	A$
Total Debt to Equity MRQ	0.60
Current Ratio MRQ	6.86
Book Value per Share MRQ	A$3.61

Cash Flow

Operating Cash Flow TTM	A$42,268,856
Levered Free Cash Flow TTM	A$31,289,070

CUV Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	50,103,800
Float Shares	39,496,161
Avg 10 Volume	91,378
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	20.45%
% Held by Institutions	8.91%

Stock Price Summary

Beta	0.74
Fifty Two Week Low	A$12.96
Fifty Two Week High	A$21.45
Fifty Two Week Change	-33.72%
Day 50 MA	A$14.50
Day 200 MA	A$16.10

Dividends and Splits

Forward Annual Dividend Rate	A$0.20
Forward Annual Dividend Yield	1.35%
Trailing Annual Dividend Rate	A$0.05
Trailing Annual Dividend Yield	0.34%
Payout Ratio	8.73%
Dividend Date
Ex Dividend Date	2023-09-05
Last Split Factor
Last Split Date	2010-11-11